Intervacc AB (FRA:2E9) Short Interest


FRA:2E9 Intervacc AB FRA:2E9
63 GF Score
Price €0.07
GF Value €0.06
! 5 Warning Signs
View Full Analysis

What is Intervacc AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:2E9 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Intervacc AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intervacc AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intervacc AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Intervacc AB's Short Interest falls into.


FRA:2E9
63GF Score
Intervacc AB FRA:2E9
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Intervacc AB (FRA:2E9) Overvalued in 2026?

Based on GuruFocus' analysis, Intervacc AB stock appears to be overvalued. The current stock price of €0.07 is trading 12.2% above its estimated GF Value™ of €0.06.

Key valuation signals for FRA:2E9:

  • Short Interest:
  • GF Value™: €0.06 vs. price of €0.07 (12.2% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the FRA:2E9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intervacc AB Business Description

Other Exchanges IVACC:Sweden
Address Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
63GF Score

Get the complete analysis for FRA:2E9

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.06
GF Value